Medicine and Dentistry
Malignant Neoplasm
100%
Immunity
100%
Messenger RNA
100%
Melanoma
100%
Immunotherapy
40%
Recurrence Risk
20%
Tumor Infiltrating Lymphocyte
20%
Recurrent Disease
20%
Bismuth Subgallate
20%
Program Evaluation
20%
Immunofluorescence
20%
Tumor Immune Microenvironment
20%
CD8 Antigen
20%
Chlordane
20%
Placebo
20%
Interferon
20%
Surgery
20%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Melanoma
100%
Messenger RNA
100%
Immunotherapy
40%
Chlordane
20%
Recurrent Disease
20%
Tumor Microenvironment
20%
Recurrence Risk
20%
Bismuth Gallate
20%
Neoplasm
20%
CD8 Antigen
20%
Interferon
20%
Placebo
20%
Biochemistry, Genetics and Molecular Biology
Messenger RNA
100%
Immunity
100%
Gene Signature
50%
RNA
25%
Immunofluorescence
25%
CD8
25%
Tumor-Associated Macrophage
25%
Tissue Section
25%
RNA Extraction
25%
CD68
25%
Interferon
25%